(Q37298913)

19 August 2017

1 reference

title

Canine ABCB1 and macrocyclic lactones: heartworm prevention and pharmacogenetics (English)

1 reference

19 August 2017

Katrina L Mealey

1

1 reference

19 August 2017

publication date

7 September 2008

1 reference

19 August 2017

published in

Veterinary Parasitology

1 reference

19 August 2017

volume

158

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

215-222

1 reference

Effect of grapefruit juice on the pharmacokinetics of cyclosporine in dogs

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Prolonged persistence of fecally excreted ivermectin from reindeer in a sub-arctic environment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Molecular biology of P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Pharmacologic circumvention of multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Bacterial multidrug resistance mediated by a homologue of the human multidrug transporter P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Regulation and expression of multidrug resistance (MDR) transcripts in the intestinal epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Enhanced bioavailability of oral docetaxel by co-administration of cyclosporin A in dogs and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of herding breed dogs living in Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Multidrug resistance genes and p-glycoprotein in the testis of the rat, mouse, Guinea pig, and human

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Clinical trials of agents that reverse multidrug resistance. A literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Increased drug delivery to the brain by P-glycoprotein inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Multidrug resistance and the role of P-glycoprotein knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

A general pattern for substrate recognition by P-glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Abamectin in the aquatic environment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

The ABC family of multidrug transporters in microorganisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Functional complementation of the ste6 gene of Saccharomyces cerevisiae with the pfmdr1 gene of Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

What determines the substrate specificity of the multi-drug-resistance pump?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.09.009

10.1016/J.VETPAR.2008.09.009

7 January 2021

Identifiers

DOI

1 reference

release_bgwxkqtbhrhx5hplux6dxjn6zq

19 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bgwxkqtbhrhx5hplux6dxjn6zq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference